Long Valley, NJ, United States of America

Bruce H Ewald

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bruce H Ewald: Innovator in Aromatase Inhibiting Compounds

Introduction

Bruce H Ewald is a notable inventor based in Long Valley, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of aromatase inhibiting compounds. His innovative work has led to the granting of a patent that showcases his expertise and creativity in this specialized area.

Latest Patents

Ewald holds a patent for "Alpha-heterocycle substituted tolunitriles." This invention focuses on compounds that inhibit aromatase, which is crucial in the treatment of certain hormone-related conditions. The patent details a complex formula involving various substituents that enhance the efficacy of these compounds. His work in this area demonstrates a deep understanding of chemical interactions and their potential therapeutic applications.

Career Highlights

Throughout his career, Bruce H Ewald has been associated with Ciba-Geigy Corporation, a company known for its advancements in pharmaceuticals and chemicals. His role at the company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovation.

Collaborations

Ewald has worked alongside notable colleagues such as Robert M Bowman and Leslie J Browne. These collaborations have likely enriched his research and development efforts, leading to more robust and effective inventions.

Conclusion

In summary, Bruce H Ewald is a distinguished inventor whose work in aromatase inhibiting compounds has made a significant impact in the pharmaceutical industry. His patent reflects his innovative spirit and dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…